Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 396

1.

Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven nonalcoholic fatty liver disease.

Nobili V, Mantovani A, Cianfarani S, Alisi A, Mosca A, Rita Sartorelli M, Maffeis C, Loomba R, Byrne CD, Targher G.

J Hepatol. 2019 Jul 4. pii: S0168-8278(19)30395-2. doi: 10.1016/j.jhep.2019.06.023. [Epub ahead of print]

PMID:
31279904
2.

Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.

Zusi C, Mantovani A, Olivieri F, Morandi A, Corradi M, Miraglia Del Giudice E, Dauriz M, Valenti L, Byrne CD, Targher G, Maffeis C.

Dig Liver Dis. 2019 Jun 26. pii: S1590-8658(19)30630-9. doi: 10.1016/j.dld.2019.05.029. [Epub ahead of print]

PMID:
31255630
4.

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management.

Lonardo A, Mantovani A, Lugari S, Targher G.

Int J Mol Sci. 2019 Jun 11;20(11). pii: E2841. doi: 10.3390/ijms20112841. Review.

5.

Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.

Mantovani A, Altomari A, Lunardi G, Bonapace S, Lippi G, Bonnet F, Targher G.

Diabetes Metab. 2019 Jun 8. pii: S1262-3636(19)30091-6. doi: 10.1016/j.diabet.2019.05.008. [Epub ahead of print]

PMID:
31185304
6.

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis.

Mantovani A, Lonardo A, Vinco G, Zoppini G, Lippi G, Bonora E, Loomba R, Tilg H, Byrne CD, Fabbri L, Targher G.

Diabetes Metab. 2019 May 5. pii: S1262-3636(19)30068-0. doi: 10.1016/j.diabet.2019.04.008. [Epub ahead of print]

PMID:
31067493
7.

Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.

Mantovani A, Turino T, Altomari A, Lonardo A, Zoppini G, Valenti L, Tilg H, Byrne CD, Targher G.

Metabolism. 2019 Jul;96:56-65. doi: 10.1016/j.metabol.2019.04.012. Epub 2019 Apr 29.

PMID:
31047909
8.

Risk of atrial fibrillation in patients with nonalcoholic steatohepatitis.

Targher G.

Liver Int. 2019 May;39(5):818-820. doi: 10.1111/liv.14049. No abstract available.

PMID:
31020773
9.

Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma.

Salvagno GL, Favaloro EJ, Demonte D, Gelati M, Poli G, Targher G, Lippi G.

Clin Chem Lab Med. 2019 Apr 2. pii: /j/cclm.ahead-of-print/cclm-2019-0135/cclm-2019-0135.xml. doi: 10.1515/cclm-2019-0135. [Epub ahead of print]

PMID:
30939111
10.

Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease.

Targher G, Lippi G.

Aliment Pharmacol Ther. 2019 Apr;49(8):1092-1093. doi: 10.1111/apt.15208. No abstract available.

PMID:
30920047
11.

Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD.

Targher G, Mantovani A, Alisi A, Mosca A, Panera N, Byrne CD, Nobili V.

Hepatology. 2019 Jul;70(1):142-153. doi: 10.1002/hep.30625. Epub 2019 May 17.

PMID:
30912854
12.

Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls.

Zoppini G, Bergamini C, Trombetta M, Sabbagh L, Dauriz M, Mantovani A, Targher G, Fossà I, Rinaldi E, Bonora E.

J Endocrinol Invest. 2019 Mar 16. doi: 10.1007/s40618-019-01032-7. [Epub ahead of print]

PMID:
30877659
13.

Letter: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density-authors' reply.

Targher G, Mantovani A, Dauriz M, Bonnet F, Byrne CD.

Aliment Pharmacol Ther. 2019 Apr;49(7):961-962. doi: 10.1111/apt.15181. No abstract available.

PMID:
30868629
14.

Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes.

Mantovani A, Altomari A, Fassio A, Gatti D, Bonnet F, Targher G.

Diabetes Metab. 2019 Mar 4. pii: S1262-3636(19)30032-1. doi: 10.1016/j.diabet.2019.02.005. [Epub ahead of print] No abstract available.

PMID:
30844448
15.

Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.

Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza GL, Valenti L, Byrne CD, Maffeis C, Bonora E, Targher G.

Diabetes Metab. 2019 Feb 11. pii: S1262-3636(19)30026-6. doi: 10.1016/j.diabet.2019.01.011. [Epub ahead of print]

PMID:
30763699
16.

Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?

Lonardo A, Ballestri S, Mantovani A, Nascimbeni F, Lugari S, Targher G.

Dig Liver Dis. 2019 Apr;51(4):462-470. doi: 10.1016/j.dld.2018.12.014. Epub 2019 Jan 2. Review.

PMID:
30733187
17.

Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis.

Mantovani A, Gatti D, Zoppini G, Lippi G, Bonora E, Byrne CD, Nobili V, Targher G.

Hepatology. 2019 Jan 31. doi: 10.1002/hep.30538. [Epub ahead of print]

PMID:
30706504
18.

Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.

Mantovani A, Dauriz M, Sandri D, Bonapace S, Zoppini G, Tilg H, Byrne CD, Targher G.

Liver Int. 2019 Apr;39(4):758-769. doi: 10.1111/liv.14044. Epub 2019 Feb 7.

PMID:
30657626
19.

Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.

Mantovani A, Dauriz M, Gatti D, Viapiana O, Zoppini G, Lippi G, Byrne CD, Bonnet F, Bonora E, Targher G.

Aliment Pharmacol Ther. 2019 Feb;49(4):375-388. doi: 10.1111/apt.15087. Epub 2019 Jan 1. Review.

PMID:
30600540
20.

The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.

Zoppini G, Bergamini C, Mantovani A, Dauriz M, Targher G, Rossi A, Bonora E.

PLoS One. 2018 Dec 27;13(12):e0209794. doi: 10.1371/journal.pone.0209794. eCollection 2018. Review.

21.

Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.

Mantovani A, Bonapace S, Lunardi G, Salgarello M, Dugo C, Gori S, Barbieri E, Verlato G, Laaksonen R, Byrne CD, Targher G.

Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2854-2861. doi: 10.1161/ATVBAHA.118.311927.

PMID:
30571175
22.

Does high LDL-cholesterol cause cardiovascular disease?

Targher G, Bonapace S, Byrne CD.

Expert Rev Clin Pharmacol. 2019 Feb;12(2):91. doi: 10.1080/17512433.2019.1561100. Epub 2018 Dec 26. No abstract available.

PMID:
30570363
23.

Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.

Mantovani A, Sani E, Fassio A, Colecchia A, Viapiana O, Gatti D, Idolazzi L, Rossini M, Salvagno G, Lippi G, Zoppini G, Byrne CD, Bonora E, Targher G.

Diabetes Metab. 2018 Oct 10. pii: S1262-3636(18)30195-2. doi: 10.1016/j.diabet.2018.10.001. [Epub ahead of print]

PMID:
30315891
24.

Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes.

Mantovani A, Rigolon R, Turino T, Pichiri I, Falceri A, Rossi A, Temporelli PL, Bonapace S, Lippi G, Zoppini G, Bonora E, Byrne CD, Targher G.

Diabetes Metab. 2018 Dec;44(6):473-481. doi: 10.1016/j.diabet.2018.08.007. Epub 2018 Sep 5.

PMID:
30195089
25.

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, Targher G.

Thyroid. 2018 Oct;28(10):1270-1284. doi: 10.1089/thy.2018.0257. Epub 2018 Aug 30.

PMID:
30084737
26.

Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study.

Mazzola R, Fersino S, Ferrera G, Targher G, Figlia V, Triggiani L, Pasinetti N, Lo Casto A, Ruggieri R, Magrini SM, Alongi F.

Med Oncol. 2018 Aug 4;35(9):121. doi: 10.1007/s12032-018-1190-8.

PMID:
30076479
27.

Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?

Targher G, Byrne CD.

Hepatology. 2018 Nov;68(5):1668-1671. doi: 10.1002/hep.30142. Epub 2018 Oct 11. No abstract available.

PMID:
30070378
28.

Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults.

Byrne CD, Patel J, Scorletti E, Targher G.

BMJ. 2018 Jul 12;362:k2734. doi: 10.1136/bmj.k2734. No abstract available.

PMID:
30002017
29.

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes.

Zoppini G, Bergamini C, Bonapace S, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G, Rossi A.

BMJ Open Diabetes Res Care. 2018 Jun 14;6(1):e000529. doi: 10.1136/bmjdrc-2018-000529. eCollection 2018.

30.

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.

Mantovani A, Dauriz M, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

Metabolism. 2018 Oct;87:1-12. doi: 10.1016/j.metabol.2018.06.004. Epub 2018 Jun 20.

PMID:
29935236
31.

Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.

Mantovani A, Bonapace S, Lunardi G, Salgarello M, Dugo C, Canali G, Byrne CD, Gori S, Barbieri E, Targher G.

Metabolism. 2018 Aug;85:305-312. doi: 10.1016/j.metabol.2018.05.006. Epub 2018 May 16.

PMID:
29777715
32.

Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure.

Valbusa F, Agnoletti D, Scala L, Grillo C, Arduini P, Bonapace S, Calabria S, Scaturro G, Mantovani A, Zoppini G, Turcato E, Maggioni AP, Arcaro G, Targher G.

Int J Cardiol. 2018 Aug 15;265:162-168. doi: 10.1016/j.ijcard.2018.04.129. Epub 2018 May 2.

PMID:
29739707
33.

Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease.

Byrne CD, Targher G.

Eur Heart J. 2018 Sep 21;39(36):3398. doi: 10.1093/eurheartj/ehy237. No abstract available.

PMID:
29726934
34.

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease.

Anstee QM, Mantovani A, Tilg H, Targher G.

Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):425-439. doi: 10.1038/s41575-018-0010-0. Review.

PMID:
29713021
35.

Mortality from infectious diseases in diabetes.

Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, Corti MC.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):444-450. doi: 10.1016/j.numecd.2017.12.007. Epub 2018 Jan 31.

PMID:
29519560
36.

Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.

Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Metabolism. 2018 Jun;83:205-215. doi: 10.1016/j.metabol.2018.02.007. Epub 2018 Mar 29.

PMID:
29477817
37.

From a fatty liver to a sugary blood.

Lonardo A, Targher G.

Dig Liver Dis. 2018 Apr;50(4):378-380. doi: 10.1016/j.dld.2018.01.126. Epub 2018 Feb 2. No abstract available.

PMID:
29422241
38.

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

Cacciatori V, Zoppini G, Bellavere F, Rigolon R, Thomaseth K, Pichiri I, Trombetta M, Dauriz M, De Santi F, Targher G, Santi L, Bonora E.

J Endocr Soc. 2017 Nov 6;2(1):53-62. doi: 10.1210/js.2017-00300. eCollection 2018 Jan 1.

39.

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.

Mantovani A, Byrne CD, Bonora E, Targher G.

Diabetes Care. 2018 Feb;41(2):372-382. doi: 10.2337/dc17-1902. Review.

PMID:
29358469
40.

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Targher G, Lonardo A, Byrne CD.

Nat Rev Endocrinol. 2018 Feb;14(2):99-114. doi: 10.1038/nrendo.2017.173. Epub 2017 Dec 29. Review.

PMID:
29286050
41.

Psoriasis and the metabolic syndrome.

Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G.

Clin Dermatol. 2018 Jan - Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005. Epub 2017 Sep 8. Review.

PMID:
29241748
42.

Clinical relevance of liver histopathology and different histological classifications of NASH in adults.

Nascimbeni F, Ballestri S, Machado MV, Mantovani A, Cortez-Pinto H, Targher G, Lonardo A.

Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):351-367. doi: 10.1080/17474124.2018.1415756. Epub 2017 Dec 26. Review.

PMID:
29224471
43.

Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.

Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11. Review.

PMID:
29137912
44.

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Lonardo A, Nascimbeni F, Mantovani A, Targher G.

J Hepatol. 2018 Feb;68(2):335-352. doi: 10.1016/j.jhep.2017.09.021. Epub 2017 Nov 6. Review.

PMID:
29122390
45.

Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis.

Dauriz M, Mantovani A, Bonapace S, Verlato G, Zoppini G, Bonora E, Targher G.

Diabetes Care. 2017 Nov;40(11):1597-1605. doi: 10.2337/dc17-0697. Review.

PMID:
29061587
46.

Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes.

Mantovani A, Rigolon R, Pichiri I, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Dec;31(12):1691-1697. doi: 10.1016/j.jdiacomp.2017.09.011. Epub 2017 Sep 20.

PMID:
29033310
47.

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.

Mantovani A, Rigolon R, Pichiri I, Bonapace S, Morani G, Zoppini G, Bonora E, Targher G.

PLoS One. 2017 Oct 5;12(10):e0185459. doi: 10.1371/journal.pone.0185459. eCollection 2017.

48.

NAFLD: Is There Anything New under the Sun?

Lonardo A, Targher G.

Int J Mol Sci. 2017 Sep 12;18(9). pii: E1955. doi: 10.3390/ijms18091955.

49.

A fatty liver leads to decreased kidney function?

Targher G, Francque SM.

J Hepatol. 2017 Dec;67(6):1137-1139. doi: 10.1016/j.jhep.2017.08.018. Epub 2017 Sep 18. No abstract available.

PMID:
28870673
50.

Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Mantovani A, Targher G.

Ann Transl Med. 2017 Jul;5(13):270. doi: 10.21037/atm.2017.04.41. Review.

Supplemental Content

Loading ...
Support Center